Narayana Hrudayalaya Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Narayana Hrudayalaya kazanç ve gelirin sırasıyla yıllık 13.6% ve 13.2% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 12.3% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 21.3% olacağı tahmin edilmektedir.

Anahtar bilgiler

13.6%

Kazanç büyüme oranı

12.3%

EPS büyüme oranı

Healthcare kazanç büyümesi	27.2%
Gelir büyüme oranı	13.2%
Gelecekteki özkaynak getirisi	21.3%
Analist kapsamı	Good
Son güncelleme	08 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

An Intrinsic Calculation For Narayana Hrudayalaya Limited (NSE:NH) Suggests It's 28% Undervalued

Oct 07

Narayana Hrudayalaya (NSE:NH) Could Become A Multi-Bagger

Sep 19

Narayana Hrudayalaya Limited's (NSE:NH) Business Is Yet to Catch Up With Its Share Price

Sep 06

Does Narayana Hrudayalaya (NSE:NH) Deserve A Spot On Your Watchlist?

Jul 20

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Jun 16

Impressive Earnings May Not Tell The Whole Story For Narayana Hrudayalaya (NSE:NH)

Jun 01

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Apr 09

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Mar 20

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Mar 04

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Dec 20

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Dec 05

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Nov 08

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Oct 21

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Aug 01

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Jul 07

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Jun 22

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Jan 19

We Think Shareholders Will Probably Be Generous With Narayana Hrudayalaya Limited's (NSE:NH) CEO Compensation

Aug 20

Narayana Hrudayalaya's (NSE:NH) Returns On Capital Are Heading Higher

Aug 07

Kazanç ve Gelir Büyüme Tahminleri

NSEI:NH - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
3/31/2027	72,207	10,817	7,641	15,063	8
3/31/2026	63,520	9,196	3,434	13,042	11
3/31/2025	55,530	7,948	-3,052	11,639	9
9/30/2024	52,206	7,787	19	11,315	N/A
6/30/2024	51,258	8,067	N/A	N/A	N/A
3/31/2024	50,184	7,893	960	10,666	N/A
12/31/2023	49,688	7,717	N/A	N/A	N/A
9/30/2023	48,933	7,375	5,102	10,323	N/A
6/30/2023	47,297	6,796	N/A	N/A	N/A
3/31/2023	45,297	6,062	5,625	10,846	N/A
12/31/2022	42,439	5,020	N/A	N/A	N/A
9/30/2022	40,755	4,457	5,587	8,093	N/A
6/30/2022	38,746	3,763	N/A	N/A	N/A
3/31/2022	37,013	3,419	2,343	4,850	N/A
12/31/2021	36,047	3,410	N/A	N/A	N/A
9/30/2021	33,954	2,843	4,082	4,783	N/A
6/30/2021	30,559	1,816	N/A	N/A	N/A
3/31/2021	25,839	-143	2,342	3,043	N/A
12/31/2020	25,049	-704	N/A	N/A	N/A
9/30/2020	25,397	-798	1,988	3,147	N/A
6/30/2020	27,677	-310	N/A	N/A	N/A
3/31/2020	31,365	1,189	3,275	4,433	N/A
12/31/2019	31,705	1,441	N/A	N/A	N/A
9/30/2019	31,152	1,254	2,191	3,691	N/A
6/30/2019	30,009	936	N/A	N/A	N/A
3/31/2019	28,740	592	1,286	2,786	N/A
12/31/2018	27,507	318	N/A	N/A	N/A
9/30/2018	25,728	332	N/A	N/A	N/A
6/30/2018	24,233	362	N/A	N/A	N/A
3/31/2018	22,943	513	N/A	1,823	N/A
12/31/2017	21,243	639	N/A	N/A	N/A
9/30/2017	20,259	668	N/A	N/A	N/A
6/30/2017	19,494	767	N/A	N/A	N/A
3/31/2017	18,884	831	N/A	2,194	N/A
12/31/2016	18,220	637	N/A	N/A	N/A
9/30/2016	17,553	525	N/A	N/A	N/A
6/30/2016	16,868	364	N/A	N/A	N/A
3/31/2016	16,176	212	N/A	1,741	N/A
12/31/2015	15,471	219	N/A	N/A	N/A
3/31/2015	13,683	-168	N/A	767	N/A
3/31/2014	10,983	317	N/A	1,100	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: NH 'nin tahmini kazanç büyümesi (yıllık 13.6% ) tasarruf oranının ( 6.7% ) üzerindedir.

Kazançlar ve Piyasa: NH şirketinin kazançlarının (yıllık 13.6% ) Indian pazarından (yıllık 18% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: NH şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: NH şirketinin gelirinin (yıllık 13.2% ) Indian pazarından (yıllık 10.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: NH şirketinin gelirinin (yıllık 13.2% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: NH 'in Özsermaye Getirisi'nin 3 yıl içinde yüksek olması tahmin ediliyor ( 21.3 %)

Narayana Hrudayalaya Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased by 8.1% to ₹1,390

Consensus EPS estimates increase by 16%

Price target increased by 8.2% to ₹1,070

Consensus EPS estimates increase by 11%

Price target increased by 7.5% to ₹943

Price target increased by 7.4% to ₹878

Recent updates

Second quarter 2025 earnings: EPS in line with expectations, revenues disappoint

Narayana Hrudayalaya Limited to Report First Half, 2025 Results on Oct 31, 2024

An Intrinsic Calculation For Narayana Hrudayalaya Limited (NSE:NH) Suggests It's 28% Undervalued

Narayana Hrudayalaya (NSE:NH) Could Become A Multi-Bagger

Now 21% undervalued

Narayana Hrudayalaya Limited's (NSE:NH) Business Is Yet to Catch Up With Its Share Price

Narayana Hrudayalaya Limited Declares Dividend for the Financial Year Ended March 31, 2024

First quarter 2025 earnings: EPS exceeds analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2025 Results on Aug 02, 2024

Upcoming dividend of ₹4.00 per share

Does Narayana Hrudayalaya (NSE:NH) Deserve A Spot On Your Watchlist?

High number of new directors

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Impressive Earnings May Not Tell The Whole Story For Narayana Hrudayalaya (NSE:NH)

Full year 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited Recommends Final Dividend for the Year Ended 31St March, 2024

Narayana Hrudayalaya Limited to Report Q4, 2024 Results on May 24, 2024

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Price target increased by 8.1% to ₹1,390

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 16%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Price target increased by 8.2% to ₹1,070

Consensus EPS estimates increase by 11%

Narayana Hrudayalaya Limited Approves Dividend for the Financial Year Ended March 31, 2023

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Narayana Hrudayalaya Limited to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended March 31, 2023

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Upcoming dividend of ₹2.50 per share at 0.3% yield

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Price target increased by 7.5% to ₹943

Full year 2023 earnings released: EPS: ₹29.85 (vs ₹16.85 in FY 2022)

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited to Report Q4, 2023 Results on May 19, 2023

Price target increased by 7.4% to ₹878

Narayana Hrudayalaya Limited Announces Board Appointments

Narayana Hrudayalaya Limited to Report Q3, 2023 Results on Feb 08, 2023

Narayana Hrudayalaya Limited Files Application for Strike-Off of Name of Wholly Owned Subsidiary, Narayana Health Institutions Private Limited

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Insufficient new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q2, 2023 Results on Nov 09, 2022

Narayana Hrudayalaya Limited (NSEI:NH) acquired Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited.

Narayana Hrudayalaya (NSE:NH) Seems To Use Debt Rather Sparingly

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited Approves the Dividend for the Financial Year Ended 31 March 2022

Upcoming dividend of ₹1.00 per share

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Is Well Worth Watching

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended 31 March 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2023 Results on Aug 08, 2022

Narayana Health Announces Appointment of Ashish Bajaj as the Chief Marketing Officer

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Full year 2022 earnings: EPS misses analyst expectations

Narayana Hrudayalaya Limited Recommends Dividend for the Year Ended March 31, 2022

Price target increased to ₹729

Insufficient new directors